Literature DB >> 8931299

Clinical aspects of 27 cases of neosporosis in dogs.

J S Barber1, A J Trees.   

Abstract

Twenty-seven cases of neosporosis in European dogs are described. The disease was confirmed by immunohistochemistry, electron microscopy, or a favourable response to treatment in the dogs with appropriate clinical signs, and by the presence of antibodies to Neospora caninum but not to Toxoplasma gondii. The affected dogs were two days to seven years old, and of 13 different breeds. Both sexes were affected and in most cases littermates remained normal. Twenty-one cases had an initial hindlimb paresis or ataxia, in which muscle atrophy was the most consistent clinical sign. Rigid hyperextension developed in approximately half of the cases. Anorexia and pyrexia were rare. Other clinical signs included forelimb ataxia, head tremors with tetraparesis and sudden collapse due to myocarditis. Titres of > or = 1:800 in the N caninum indirect fluorescent antibody test were detected in the 20 cases from which serum samples were taken. Such high titres are rare in healthy dogs and strongly suggest a diagnosis of neosporosis. Sixteen of the dogs received appropriate antiprotozoal treatment with clindamycin, potentiated sulphonamides and/or pyrimethamine; 10 made a full or functional recovery. Recovery was less likely in peracute cases with severe clinical signs, and when the treatment was delayed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8931299     DOI: 10.1136/vr.139.18.439

Source DB:  PubMed          Journal:  Vet Rec        ISSN: 0042-4900            Impact factor:   2.695


  23 in total

1.  Treatment of canine pediatric Neospora caninum myositis following immunohistochemical identification of tachyzoites in muscle biopsies.

Authors:  Jennifer L Crookshanks; Susan M Taylor; Deborah M Haines; G Diane Shelton
Journal:  Can Vet J       Date:  2007-05       Impact factor: 1.008

Review 2.  A review of immunologic diseases of the dog.

Authors:  N C Pedersen
Journal:  Vet Immunol Immunopathol       Date:  1999-08-02       Impact factor: 2.046

3.  Systemic disseminated Neospora caninum infection with cutaneous lesions as the initial clinical presentation in a dog.

Authors:  Magali Decôme; Edouard Martin; Liza Bau-Gaudreault; Elizabeth O'Toole
Journal:  Can Vet J       Date:  2019-11       Impact factor: 1.008

4.  Prevalence of antibodies to Neospora caninum in stray dogs of Urmia, Iran.

Authors:  Mohammad Yakhchali; Shahram Javadi; Ahmad Morshedi
Journal:  Parasitol Res       Date:  2010-04-09       Impact factor: 2.289

5.  Serologic study of anti-Neospora caninum antibodies in household dogs and dogs living in dairy and beef cattle farms in Tehran, Iran.

Authors:  A Malmasi; M Hosseininejad; H Haddadzadeh; A Badii; A Bahonar
Journal:  Parasitol Res       Date:  2006-11-22       Impact factor: 2.289

6.  Disseminated Neospora caninum infection in a dog with severe colitis.

Authors:  Benjamin Curtis; Adam Harris; Tarini Ullal; Paula A Schaffer; Juan Muñoz Gutiérrez
Journal:  J Vet Diagn Invest       Date:  2020-09-19       Impact factor: 1.279

7.  Loss of infectivity of Neospora caninum oocysts maintained for a prolonged time.

Authors:  Rosangela Soares Uzeda; Kattyanne De Souza Costa; Sara Lima Santos; Alexandre Moraes Pinheiro; Maria Angela Ornelas De Almeida; Milton M McAllister; Luis Fernando Pita Gondim
Journal:  Korean J Parasitol       Date:  2007-12       Impact factor: 1.341

8.  Effects of Neospora caninum infection on brain microvascular endothelial cells bioenergetics.

Authors:  Hany M Elsheikha; Charlotte L McKinlay; Nashwa A Elsaied; Paul A Smith
Journal:  Parasit Vectors       Date:  2013-01-25       Impact factor: 3.876

9.  Host cells participate in the in vitro effects of novel diamidine analogues against tachyzoites of the intracellular apicomplexan parasites Neospora caninum and Toxoplasma gondii.

Authors:  Angela Leepin; Angela Stüdli; Reto Brun; Chad E Stephens; David W Boykin; Andrew Hemphill
Journal:  Antimicrob Agents Chemother       Date:  2008-03-24       Impact factor: 5.191

10.  Di-cationic arylimidamides act against Neospora caninum tachyzoites by interference in membrane structure and nucleolar integrity and are active against challenge infection in mice.

Authors:  Michelle Schorer; Karim Debache; Fabienne Barna; Thierry Monney; Joachim Müller; David W Boykin; Chad E Stephens; Andrew Hemphill
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2012-04-02       Impact factor: 4.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.